For personal use only. Investor Briefing. Bayswater, 1 st December 2016

Transcription

1 Investor Briefing Bayswater, 1 st December 2016

2 Introduction Samantha Cheetham Chief Executive Officer

3 To be an innovative leader in the dental industry, developing our people and partnering with dentists and distributors globally to help them deliver a superior patient experience. THE SDI VISION We exist to increase shareholder value by discovering, developing and marketing top quality, innovative dental products. THE SDI MISSION

4 Overview ASX:SDI listed 7 th November 1985 Current share price: $0.76 ( ) Market cap - $90.3m ( ) BACKGROUND Founded in 1971 Australia s largest dental manufacturer All research, development and manufacturing is in Melbourne 265 staff worldwide Offices in São Paulo, Brazil; Chicago, USA; Cologne, Germany Worldwide distribution with 500+ distributors Numerous national and international awards, including Australian Exporter of the Year for Health and Biotechnology

5 Video To view video visit:

6 Manufacturing Barry Alderson Manufacturing Manager

7 A Lean culture What is Lean? Simply, the elimination of waste Why do Lean? To drive improvements and to enhance workforce engagement Create capacity to enable SDI to deliver $120m+ in sales Create capability to resolve problems, create robust processes, embed Lean thinking in the culture at SDI

8 Lean benefits Customer service Last 6 months: Intercompany delivery performance 96.9% Last 6 months: Export delivery improvement of 33% Cost Reduction Elimination of the wastes, building future capability and capacity without incurring additional labour expenses Cultural Change High levels of engagement, participation, knowledge and understanding

9 R+D Chemistry Paul Farrar R&D Manager

10 R+D leads product mix change 100% 90% 10% 9% 9% 9% 9% 80% 70% 22% 25% 25% 30% 33% 60% 50% 40% 21% 21% 23% 22% 25% 30% 20% 47% 45% 43% 39% 33% 10% 0% amalgam whitening aesthetics equipment

11 Innovation is key Strong pipeline of products Concentrating on categories that deliver high sales margins 1 2 new products per year to drive growth Building on SDI s world-leading technical expertise, particularly in glass ionomers and tooth whitening. Very focused R+D teams collaborating closely with researchers and innovation centers globally o ARC Linkage grant with UNSW ($360K / 3 year) o Innovations Connections grant with Monash Uni ($40K / 1 year) o Project work with Tufts Dental School (Boston, USA) 2016/17 product releases Aura Easy - composite - rollout happening now Pola Luminate - tooth whitening - December 2016 Riva Cem - a paste/paste cement - January 2017 Radii Xpert small equipment - April 2017

12 Product Strategy Vertically integrated global dental manufacturer Products for expanding market segments with very few players Example: Glass Ionomer Cements Estimated market value > USD 200M Two main players (GC Dental, 3M Oral Care) Continual investment to extend current areas of technical expertise Materials chemistry development (whitening, composites, glass ionomers) Liquid development (projects with Monash University) Equipment (applicators, high-speed mixers, curing lights, etc) Working towards a white amalgam

13 R+D delivery systems, glass Dr. Joshua Cheetham Chief Technology Officer

14 Delivery innovation Delivery packaging GIC capsule system projects o New and improved capsule versions o Supplying competitors Teeth whitening delivery system innovation projects Unit-dose and syringe-type delivery packaging systems Multi-cavity tooling upgrades Multiple patents applied and granted globally Automation Specialized high speed manufacturing cells designed and built at SDI to fill and assemble delivery systems focusing on three areas: o Composite o Glass Ionomer o Teeth whitening

15 Advanced Glass Technology Glass Development and commercialization of high purity glass powders for dental manufacturing Current size capability >200nm Reactive glasses (for GIC type material) and Inert glasses (for composite material) Supplies all of SDI s glass products for GIC and composite Focus on new glass products and processes Sales to competitors are growing Major refurbishment and upgrade to glass manufacturing facility completed in 2016 Technology and glass manufacturing efficiencies Foundation for future glass product expansion To become the leading glass manufacturer for the dental industry

16 Regulatory Ray Cahill Chief Quality & Compliance Officer

17 Barriers to entry COMPLIANCE ISO Audited directly by visits from: TGA AUSTRALIA UL - AUSTRALIA CE - EUROPE HEALTH CANADA CSA - CANADA MHLW - JAPAN ANVISA BRAZIL FDA KOREA GCC SAUDI ARABIA Indirect audits from 100+ countries Eg. FDA - USA PRODUCT REGISTRATION Products are medical devices Registration is required in 100+ countries directly or through consultants or distributors Worldwide regulatory team

18 Financials John Slaviero Director of Finance and COO

19 Currency/margin Margin is determined by: Sales mix by region Product sales mix Currency variations Production efficiencies Cost base in AUD Product Margins: % % % Low Margin Markets: Brazil Australian Exports High Margin Markets: Europe North America Australia F/X Adjustments: Gross Profit Margin Operating Expenses Cash Translations - Realised Gains / Losses Revaluation of Assets & Liabilities - Unrealised Gains / Losses

20 Currency Average Currency Movements 2013 /14 Movement 2014 / 15 Movement 2015 / 16 Movement Loss / (gain) Loss / (gain) Loss / (gain) AUD / USD % % % AUD / EUR % % % EUR / GBP % % % CAD / USD % % % AUD / BRL % % End Period Rates 2013 /14 Movement 2014 / 15 Movement 2015 / 16 Movement Loss / (gain) Loss / (gain) Loss / (gain) AUD / USD % % % AUD / EUR % % % EUR / GBP % % % CAD / USD % % % AUD / BRL % % % End of year rates set the average for the new year

21 Questions